Skip to main content

Biography

Amber Southwell’s research involves preclinical therapy and strategies for inherited neurological diseases, specifically for Huntington disease (HD). Southwell has developed several novel mouse models of HD, a selective mutant Huntington gene silencing therapy, and a cerebrospinal fluid (CSF) biomarker for brain Huntington.

Areas of Focus

Innovation. Partnership. Impact. Our integrated approach to teaching, learning and research unleashes the potential of our faculty and students — empowering them to make a difference in their communities and around the world.

Space Technologies & Systems
Entertainment & Immersive Experiences
Health & Human Performance
Energy & Sustainability
Transformative Technologies & National Security